Posted on Thursday, 30th June 2011 by Brooke Richmond
Widespread screening with CT scans can detect lung cancer. Regular mammograms of all women 40 and older can find breast cancer. Avastin, at $8,000 a month, has helped some patients with advanced breast cancer. And the prostate cancer drug Provenge, at $93,000 per patient, can extend survival by about four months. Such were the headlines this week. But this made headlines too: Healthcare spending in the U.S. outpaces all other industrialized countries, amounting to 17.5% of our economic output. And we don’t have the life expectancy to show for it. The question currently being asked is: At what point can we — should we — say: “Enough”?
But for most people, the honest answer depends on two things: 1) whether they or a stranger have the condition and 2) who’s footing the bill. So … who should foot the bill? Tell us what you think below.
Similar Posts:
- Breathalyzer ‘sniffs out’ breast cancer
- Risk for premenopausal smokers
- New study: Lifting weights helps not harms breast cancer survivors
- TSA introduces breast cancer screening procedure as new benefit of airport security pat-downs (satire)
- Minn. Radio Show Host Shares Experiences With Breast Cancer
Tags: Avastin, Ct Scans
Posted in Health Notes | No Comments »